Francisco Ruiz-Cabello

Author PubWeight™ 37.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology 2011 2.01
2 Expanded cells in monoclonal TCR-alphabeta+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis recognize hCMV antigens. Blood 2008 1.61
3 The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape. Cancer Immunol Immunother 2004 1.31
4 MHC class I antigens and immune surveillance in transformed cells. Int Rev Cytol 2007 1.24
5 Analysis of HLA-E expression in human tumors. Immunogenetics 2003 1.23
6 Role of altered expression of HLA class I molecules in cancer progression. Adv Exp Med Biol 2007 1.22
7 Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes. Cancer Immunol Immunother 2012 1.15
8 High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer. Hum Immunol 2007 1.08
9 Analysis of IL-10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcome. J Hepatol 2008 1.04
10 Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies. Haematologica 2004 1.04
11 Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy. Immunogenetics 2008 1.03
12 Analysis of HLA expression in human tumor tissues. Cancer Immunol Immunother 2002 1.03
13 Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer. BMC Cancer 2008 0.99
14 Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events. Int J Cancer 2003 0.97
15 Monoclonal TCR-Vbeta13.1+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis: evidence for an antigen-driven chronic T-cell stimulation origin. Blood 2007 0.95
16 IFN inducibility of major histocompatibility antigens in tumors. Adv Cancer Res 2008 0.94
17 Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancer. Hum Immunol 2012 0.93
18 Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer. Int J Cancer 2005 0.91
19 HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank. Cancer Immunol Immunother 2009 0.90
20 HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination. Cancer Immunol Immunother 2006 0.89
21 VEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish population. Hum Immunol 2012 0.88
22 Study of six X-linked tetranucleotide microsatellites: population data from five Spanish regions. Int J Legal Med 2005 0.88
23 HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity. PLoS One 2013 0.87
24 Analysis of HLA-ABC locus-specific transcription in normal tissues. Immunogenetics 2010 0.86
25 Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma. Int J Cancer 2013 0.86
26 Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines. Cancer Immunol Immunother 2007 0.85
27 Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines. BMC Cancer 2007 0.85
28 Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idiosyncratic drug-induced liver injury. Liver Int 2013 0.84
29 Identification of different tumor escape mechanisms in several metastases from a melanoma patient undergoing immunotherapy. Cancer Immunol Immunother 2006 0.83
30 A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma. Hum Immunol 2008 0.82
31 Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients. Hum Immunol 2010 0.82
32 Late pulmonary metastases of renal cell carcinoma immediately after post-transplantation immunosuppressive treatment: a case report. J Med Case Rep 2008 0.81
33 Genome-wide differential genetic profiling characterizes colorectal cancers with genetic instability and specific routes to HLA class I loss and immune escape. Cancer Immunol Immunother 2011 0.81
34 Changes in activatory and inhibitory natural killer (NK) receptors may induce progression to multiple myeloma: implications for tumor evasion of T and NK cells. Hum Immunol 2009 0.81
35 Acute myeloid leukaemia of donor cell origin developing 17 years after allogenic hematopoietic cell transplantation for acute promyelocytic leukaemia. Int J Biomed Sci 2012 0.81
36 High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity. Cancer Immunol Immunother 2004 0.80
37 Leukocyte infiltrate in gastrointestinal adenocarcinomas is strongly associated with tumor microsatellite instability but not with tumor immunogenicity. Cancer Immunol Immunother 2011 0.80
38 Clinical significance of langerhans cells in squamous cell carcinoma of the larynx. J Oncol 2012 0.76
39 Correction: Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish Cohort. PLoS One 2015 0.75
40 Natural killer cell receptor expression reflects the role of human cytomegalovirus in the pathogenesis of a subset of CD4+ T-cell large granular lymphocytosis. Hum Immunol 2010 0.75
41 Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen alleles. Pharmacogenet Genomics 2016 0.75
42 Evaluation of functional single nucleotide polymorphisms of different genes coding for the immunoregulatory molecules in patients with monoclonal large granular lymphocyte lymphocytosis. Hum Immunol 2008 0.75
43 Diffuse large B-cell lymphoma in a renal allograft associated with Epstein-Barr virus in the recipient: a case report and a review of lymphomas presenting in a transplanted kidney. Clin Transplant 2008 0.75